Recce Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Cash & Equivalents	10.45	4.42	1.56	11.58	20.87	Upgrade
Short-Term Investments	0.24	-	-	-	-	Upgrade
Cash & Short-Term Investments	10.69	4.42	1.56	11.58	20.87	Upgrade
Cash Growth	142.02%	182.74%	-86.52%	-44.51%	678.21%	Upgrade
Other Receivables	0.2	0.16	0.09	0.18	0.25	Upgrade
Receivables	0.2	0.16	0.09	0.18	0.25	Upgrade
Other Current Assets	0.5	0.56	0.3	0.42	0.06	Upgrade
Total Current Assets	11.39	5.14	1.95	12.18	21.18	Upgrade
Property, Plant & Equipment	1.03	1.23	0.61	0.44	0.5	Upgrade
Other Intangible Assets	0	0	-	0	0	Upgrade
Total Assets	12.41	6.37	2.56	12.62	21.68	Upgrade
Accounts Payable	2.18	3.97	0.95	0.48	0.49	Upgrade
Accrued Expenses	0.93	0.57	0.41	0.38	0.39	Upgrade
Short-Term Debt	-	9.69	3.05	-	-	Upgrade
Current Portion of Long-Term Debt	1.53	-	-	-	-	Upgrade
Current Portion of Leases	0.22	0.22	0.15	0.07	0.11	Upgrade
Other Current Liabilities	1.27	0.62	0.29	1.51	0.09	Upgrade
Total Current Liabilities	6.13	15.07	4.85	2.45	1.08	Upgrade
Long-Term Debt	8.6	-	-	-	-	Upgrade
Long-Term Leases	0.42	0.59	0.1	-	0.01	Upgrade
Pension & Post-Retirement Benefits	0.32	0.24	0.19	0.12	0.09	Upgrade
Other Long-Term Liabilities	0	-0	-	0	-	Upgrade
Total Liabilities	15.47	15.89	5.14	2.56	1.18	Upgrade
Common Stock	81.5	54.84	44.11	43.97	43.3	Upgrade
Retained Earnings	-91.5	-70.08	-55.54	-42.46	-31.47	Upgrade
Comprehensive Income & Other	6.95	5.71	8.83	8.55	8.68	Upgrade
Shareholders' Equity	-3.05	-9.52	-2.59	10.06	20.5	Upgrade
Total Liabilities & Equity	12.41	6.37	2.56	12.62	21.68	Upgrade
Total Debt	10.77	10.5	3.3	0.07	0.13	Upgrade
Net Cash (Debt)	-0.08	-6.09	-1.74	11.51	20.75	Upgrade
Net Cash Growth	-	-	-	-44.53%	698.25%	Upgrade
Net Cash Per Share	-0.00	-0.03	-0.01	0.07	0.13	Upgrade
Filing Date Shares Outstanding	288.37	231.61	196.83	178.02	173.78	Upgrade
Total Common Shares Outstanding	288.37	203.99	178.25	177.65	173.78	Upgrade
Working Capital	5.26	-9.93	-2.9	9.74	20.1	Upgrade
Book Value Per Share	-0.01	-0.05	-0.01	0.06	0.12	Upgrade
Tangible Book Value	-3.05	-9.52	-2.59	10.06	20.5	Upgrade
Tangible Book Value Per Share	-0.01	-0.05	-0.01	0.06	0.12	Upgrade
Machinery	0.95	0.92	0.79	0.74	0.62	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.